TruAlt Bioenergy Limited

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has informed the Exchange about the appointment of a Scrutinizer for the remote e-voting process in a fair and transparent manner for the 5th Annual General Meeting.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has appointed Mr. Mallikarjun Bhimappa Dyaberi as Chairman of the Board, effective July 28, 2026, for a period of one year.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has informed the Exchange regarding the cessation of Mr. Yagati Badarinarayana Ramakrishna as Chairman and Independent Director of the Company, effective July 28, 2026.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has informed the Exchange regarding the appointment of scrutinizer, Mr. Deepak Sadhu, for the 5th Annual General Meeting.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has submitted its financial results for the quarter ended June 30, 2026, along with a limited review report. The results will be available on the company's website and in a newspaper advertisement.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has informed the Exchange about Schedule of Investors/Analyst Earnings Conference Call for Q1 FY 2026-27. The call will be held on July 29, 2026, at 11:00 A.M. (IST) to discuss financial results. The call will be recorded and made available on the Company’s website.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has informed the Exchange regarding voting results along with copy of scrutinizers report together with copy of minutes.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, stating that the entire holding of the Company's shares are in demat form and no requests for rematerialisation or dematerialization were received during the quarter ended June 30, 2026.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has closed its trading window for insiders due to SEBI regulations, effective July 1, 2026, until 48 hours after the Q1 2026 financial results announcement.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has resubmitted its audited financial results for the quarter and year ended March 31, 2026, correcting an earlier submission that was not machine-readable. The resubmitted standalone results indicate a significant decline in performance, with full-year revenue from operations decreasing to ₹1,70,465.34 lakhs in FY26 from ₹1,88,011.66 lakhs in FY25. Net profit for the year substantially dropped to ₹8,003.00 lakhs compared to ₹14,061.53 lakhs in the previous year, resulting in lower earnings per share (EPS) of ₹10.23 against ₹20.08 in FY25.

TruAlt Bioenergy Limited

Vijaykumar Murugesh Nirani, a member of the Promoter/Promoter Group of TruAlt Bioenergy Limited, has submitted a disclosure under Regulation 31(4) of the SEBI Takeover Regulations. The filing confirms that the promoter group has not created any new encumbrances on the company's shares, directly or indirectly, during the financial year 2025-26, beyond those already disclosed to the stock exchanges. This is a routine compliance declaration.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has received approval for financial assistance of ₹150 crore under the Government of India's PM JI-VAN Yojana for its proposed commercial-scale Sustainable Aviation Fuel (SAF) project.

TruAlt Bioenergy Limited

TruAlt Bioenergy Limited has received ₹150 crore financial assistance approval under PM JI-VAN Yojana for its proposed commercial-scale Sustainable Aviation Fuel (SAF) project at Bagalkot, Karnataka.